WebApr 6, 2024 · Delcath Systems Closes Private Placement of $5.0 Million. NEW YORK , July 20, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announc... 9 months ago - PRNewsWire. WebApr 10, 2024 · A high-level overview of Delcath Systems, Inc. (DCTH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
DCTH Stock Price Forecast. Should You Buy DCTH? - StockInvest.us
WebDCTH Stock Price - Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. ... It’s calculated by averaging the closing stock price over the previous 50 trading days. Delcath Systems Inc 50-day moving average is $4.88. WebApr 6, 2024 · DCTH Stock Overview. Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. ... Price History & Performance. Summary of all time highs, changes and price drops for Delcath Systems; Historical stock prices; Current Share Price: … black cowboy festival 2021
Delcath Systems, Inc. (DCTH) Stock Price Today, Quote & News
WebStock split history for Delcath Systems since 2024. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to ... WebMar 31, 2024 · Delcath Systems (NASDAQ:DCTH) Historical Stock Chart From Mar 2024 to Apr 2024 Delcath Systems (NASDAQ:DCTH) Historical Stock Chart From Apr 2024 … WebApr 2, 2024 · Discover historical prices for DCTH stock on Yahoo Finance. View daily, weekly or monthly formats back to when Delcath Systems, Inc. stock was issued. blackcowboyfestival.net